HomeATM CEO Appointed to Heart Health Advisory Board

Heart Health Inc. Appoints Innovator with 25 Patents to Advisory Board

Heart Health Inc. Appoints Innovator with 25 Patents to Advisory Board

(Marketwire Via Acquire Media NewsEdge) MONTREAL, QUEBEC, October 2 / MARKET WIRE/ --

Heart Health Inc. (OTCPK: HHEL) is pleased to announce that the Company has appointed Kenneth G. Mages, the founder and CEO of HomeATM Payments and a contributing developer of the Heart Health Monitor (HHM), to its advisory board.

He will assist the company with research and development, writing patents, and developing new applications for the HHM as it moves toward FDA approval.

Mr. Mages graduated from the University of Illinois with a B.A. in Business Administration and Computer Science in 1978. He has more than 25 years of experience in leadership positions serving as CEO HomeATM and KGM Graphics Inc., CTO of Planetportal.com, and Director of BioBank LLC before it became HomeATM. He has contributed to the filings of 25 patents, including one for a method to enable secure transmission of PINs over the internet, and another for a DOS-based system to digitize artwork for the comic industry.

"We are honored to have Mr. Mages join our advisory board. Fundamentally, as a contributing developer of the HHM, his expertise will help us move forward with its design, and his vast experiences in diverse leadership roles will be an enormous asset in our abilities to achieve our ultimate goal of revolutionizing the heart monitoring industry," stated Michael Kron, Chairman and CEO of Heart Health, Inc.

Heart Health Inc. continues to move forward with the development and marketing of its GSM and USB enabled Heart Health Monitor. This device will allow patients to instantaneously e-mail or print their EKG results, enabling a trained medical professional to make a quicker diagnosis of the user's heart condition.

About Heart Health, Inc.:

Heart Health, Inc. is a holding company focused on the development and marketing of innovative, cardiovascular medical device products. The Company intends to revolutionize the way in which people monitor the health of their hearts using newly acquired products such as the Heart Health Monitor.

Safe Harbor Act: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

Contacts:
Heart Health Inc.
Investor Relations
1-866-THE-APPL(E)